Rahman, S., Zhang, Z., Papke, R. L., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2008). Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. British Journal Of Pharmacology, 153(4), 792-804. https://doi.org/10.1038/sj.bjp.0707612
Dwoskin, L. P., Joyce, B. M., Zheng, G., Neugebauer, N. M., Manda, V. K., Lockman, P., et al. (2007). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021(Original work published 2007)
